Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-26 Sale |
2024-08-28 4:26 pm |
ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) |
View |
| 2024-08-21 Sale |
2024-08-23 6:38 pm |
ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) |
View |
| 2024-04-03 Sale |
2024-04-05 4:33 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
8,009,729 | $0 | $0 | 0 (Indirect) |
View |
| 2023-08-29 Purchase |
2023-08-31 5:26 pm |
ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
500,000 | $6.2 | $3,100,000 | 9,240,887 (Indirect) |
View |
| 2023-05-22 Purchase |
2023-05-24 5:09 pm |
Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
869,565 | $5.75 | $4,999,999 | 10,646,056 (Indirect) |
View |
| 2023-05-04 Purchase |
2023-05-08 5:22 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) |
View |
| 2023-04-28 Purchase |
2023-05-02 9:34 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) |
View |
| 2022-07-01 Sale |
2022-07-01 4:50 pm |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner |
1,964,770 | $55 | $108,062,350 | 0 (Indirect) |
View |
| 2022-06-24 Sale |
2022-06-28 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner |
341,971 | $21.31 | $7,287,402 | 415,142 (Indirect) |
View |
| 2022-04-06 Sale |
2022-04-08 6:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner |
878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) |
View |
| 2022-03-29 Sale |
2022-03-31 5:30 pm |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner |
474,500 | $21.63 | $10,264,415 | 6,589,330 (Indirect) |
View |
| 2022-02-11 Purchase |
2022-02-15 9:42 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director |
195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) |
View |
| 2021-09-03 Sale |
2021-09-08 6:18 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
8,084 | $33.99 | $274,794 | 96,190 (Indirect) |
View |
| 2021-08-31 Sale |
2021-09-02 8:27 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) |
View |
| 2021-08-26 Sale |
2021-08-30 6:37 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,073 | $34.07 | $615,748 | 97,542 (Indirect) |
View |
| 2021-08-23 Sale |
2021-08-25 8:43 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,215 | $34.17 | $622,426 | 98,074 (Indirect) |
View |
| 2021-08-17 Sale |
2021-08-19 8:55 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
20,328 | $34.1 | $693,210 | 98,610 (Indirect) |
View |
| 2021-07-16 Purchase |
2021-07-16 4:27 pm |
IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 7:09 pm |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,666,666 | $18 | $29,999,988 | 883,418 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:41 pm |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 6:11 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
750,000 | $20 | $15,000,000 | 450,000 (Indirect) |
View |
| 2020-10-02 Purchase |
2020-10-06 5:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
| 2020-09-25 Purchase |
2020-09-29 8:10 pm |
Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,236,800 | $19 | $23,499,200 | 14,805,377 (Indirect) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:39 pm |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
950,000 | $18 | $17,100,000 | 475,000 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
898,000 | $17 | $15,266,000 | 192,100 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:53 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
774,200 | $20 | $15,484,000 | 99,200 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-17 Option Award |
2023-02-23 2:16 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
550,000 | $0 | 4,593,629 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
431,206 | $13.2 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
487,450 | $0 | 226,704 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 7:09 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
20,654,719 | $0 | 883,418 (Indirect) |
View |
Ownership |
2021-02-11 9:20 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner |
0 | $0 | 3,278,526 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:24 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
3,240,882 | $0 | 534,599 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:41 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 8:10 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
27,775,930 | $0 | 14,805,377 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:39 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
6,114,330 | $0 | 475,000 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
14,102,821 | $0 | 192,100 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 5:53 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
2,601,325 | $0 | 99,200 (Indirect) |
View |